Positive donor blood cultures are not associated with worse heart transplant survival.

Abstract

Recent evidence has demonstrated that transplantation of hearts with blood culture positive donors (BCPDs) to pediatric recipients is safe and effective. Few studies have analyzed the effect of BCPD on adult heart transplant recipients. The United Network for Organ Sharing (UNOS) database was retrospectively reviewed from September, 1987 to March, 2021. Exclusion criteria included pediatric donors/recipients, donor ejection fraction <10% or >85%, inactive listed recipients, donors missing blood cultures, and recipients missing follow-up time. Outcomes were compared with fully adjusted logistic models. To account for discrepancies in BCPD and non-BCPD covariates, an inverse proportionally weighted model with regression adjustment (IPWRA) was used. A total of 60592 donors were non-BCPD, while 4009 were BCPD. 7% of hearts not transplanted were BCPD, while 6% of hearts transplanted were BCPD (p=.001). These rates have been nearly constant since 2005. There were no differences in short term survival between the two groups in the adjusted or IPWRA models (p=.103 and .277, respectively). Additionally, the BCPD group had longer ischemic time (3.24 vs. 3.06h, p<.001), older donor age (32.73 vs. 31.65years, p<.001), and older recipient age (52.76 vs. 52.09years, p=.001). The IPWRA revealed an average additional 3.4years of overall survival and 2.25years of graft function for BCPD versus non-BCPD recipients, although these results failed to reach statistical significance (p=.387 and .527, respectively). Given the need for more donor hearts, donors with positive blood cultures should be considered. Great care in evaluating such patients is advised to eliminate donors with untreated infections, while carefully selected donors can be considered and used.